Lilly sues compounders over unapproved versions of Mounjaro; needle-free anaphylaxis treatment runs into an FDA roadblock

Taking stock of the drug industry, from the lab to the medicine chest

September 20, 2023 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Darron Cummings/AP STAT+ | Lilly sues compounders, wellness centers and spas over unapproved versions of Mounjaro The move comes as more Americans clamor for medicines to lose weight, causing shortages and boosting sales of compounded versions. By Ed Silverman A needle-free anaphylaxis treatment runs into an FDA roadblock A nasal epinephrine spray called neffy, if approved, would present an alternative to EpiPens for people at risk of severe allergic reactions. By Isabella Cueto STAT+ | Novartis is scolded by U.K. trade group for the fourth time this year over Entresto promotions Novartis was cited for hosting an online event to discuss heart failure but the virtual meeting essentially amounted to a promotional event. By Ed Silverman Molly Ferguson/STAT STAT+ | The Apellis eye drug rebound accelerates. This time, it's a competitor falling behind In market battle of drugs for a common type of vision loss, Syfovre by Apellis gains upper hand as questions linger on Astellas' Izervay. By Adam Feuerstein Free Covid tests will be offered again to all U.S. households The Biden administration is offering Covid tests to meet current needs, and to stimulate a testing industry that has faced cratering demand. By Helen Branswell and Rachel Cohrs STAT+ | How a cash-prize system that phases out patents may lower drug prices In the plan, the government would finance more drug research and award cash prizes to companies when they invent drugs or hit milestones. By Ed Silverman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser